These amino acids have been reported to ameliorate intestinal inflammation by suppressing nuclear factor κB (NF-κB) and mitogen-activated protein kinase (MAPK) pathways associated with osteoporosis (24, 25). Here, NFKB1 is linked to osteoporosis.